FDA Import Refusal 1FX-6752812-5/10002/3 — Intas Pharmaceuticals Limited
The FDA refused shipment 1FX-6752812-5/10002/3 from Intas Pharmaceuticals Limited (India) on Aug 13, 2026. The refused product falls under Drugs and Biologics — OLANZAPINE (TRANQUILIZER (ANTI-PSYCHOTIC) - PART II. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 13, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66NDA02 OLANZAPINE (TRANQUILIZER (ANTI-PSYCHOTIC) - PART II
- Charges
- 75